Streetbeat News

Price Targets

PXD

Over the past 3 months, 12 Wall Street analysts have provided ratings for Pioneer Natural Resources (NYSE:PXD), with an average 12-month price target of $256.42, which is a 4.48% decrease from the previous target of $268.44. The ratings include 2 bullish, 9 indifferent, and 1 somewhat bearish. Analysts use various data sources to predict stock performance, and their ratings are considered important indicators for investors.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 5:00 pm

PR

UBS has maintained a Neutral rating for Permian Resources (NYSE:PR) but lowered its price target from $15.00 to $14.00. Permian Resources' shares are currently trading at $13.15, up 0.84% over the last 24 hours. The new price target suggests a potential upside of 6.46% from the current share price. Permian Resources is an independent oil and natural gas company.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 5:00 pm

BLTE

Over the past 3 months, 4 Wall Street analysts have consistently given Belite Bio (NASDAQ:BLTE) a bullish rating. The average 12-month price target for BLTE is $58.75, with a high of $60.00 and a low of $57.00, marking a 6.82% increase from the previous target of $55.00. Analysts' ratings are based on research, financial statements, and insider information, and are updated typically once a quarter.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 5:00 pm

CNM

Goldman Sachs has maintained a Neutral rating for Core & Main (NYSE:CNM) but raised its price target from $38.00 to $42.00. Core & Main's shares are currently trading down at $37.85, which is a 2.7% decrease over the last 24 hours. The new price target suggests a potential upside of 10.96% from the current share price.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 5:00 pm

SAIA

Benchmark analyst Christopher Kuhn has reiterated a Buy rating on Saia (NASDAQ:SAIA) and maintained a $475 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 4:57 pm

XOM

UBS analyst Jon Rigby has maintained a Buy rating on Exxon Mobil (NYSE:XOM) but has reduced the price target from $138 to $133.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 4:52 pm

TRGP

UBS analyst Shneur Gershuni has maintained a Buy rating on Targa Resources (NYSE:TRGP) but has reduced the price target from $116 to $109.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 4:50 pm

PXD

UBS analyst Josh Silverstein has maintained a Neutral rating on Pioneer Natural Resources (NYSE:PXD) and reduced the price target from $269 to $250.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 4:49 pm

PR

UBS analyst Josh Silverstein has maintained a Neutral rating on Permian Resources (NYSE:PR) but has lowered the price target from $15 to $14.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 4:48 pm

PFE

UBS analyst Colin Bristow has maintained a Neutral rating on Pfizer (NYSE:PFE) and reduced the price target from $34 to $27.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 4:47 pm